|
Market Closed -
Nasdaq
06:00:00 12/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 8.120 USD | -2.05% |
|
-18.47% | +4.10% |
Stock exchange
Nasdaq
BCRX 8.120 $
-2.05%
29.17M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| BCRX | 8.120USD | -2.05% | 29.17M $ | ||
CBOE
| BCRX | 8.115USD | -2.23% | 768K $ | |
|
Tradegate
| BO1 | 6.998EUR | -2.04% | 9.27K € | |
|
Mexican S.E.
| BCRX * | 182.00MXN | -6.67% | 18.2K $ | |
|
Boerse Muenchen
| BO1 | 7.038EUR | -1.40% | 49.27 € | |
|
Deutsche Boerse AG
| BO1 | 7.074EUR | -5.71% | 0 € | |
|
Börse Stuttgart
| BO1 | 7.006EUR | -1.46% | 0 € | |
|
Berne S.E.
| BO1 | 6.676CHF | +1.13% | 0 CHF |
Quotes 5-day view: BioCryst Pharmaceuticals, Inc.
Delayed Quote Nasdaq
| 04/09/2026 | 08/09/2026 | 09/09/2026 | 10/09/2026 | 11/09/2026 | |
|---|---|---|---|---|---|
| Last | USD 9.960 | USD 9.065 | USD 8.805 | USD 8.290 | USD 8.120 |
| Volume | 1,495,739 | 9,687,920 | 5,152,521 | 9,001,379 | 3,591,765 |
| Change | -1.29% | -8.99% | -2.87% | -5.85% | -2.05% |
| Opening | USD 10.00 | USD 9.122 | USD 9.070 | USD 8.340 | USD 8.300 |
| High | USD 10.10 | USD 9.400 | USD 9.230 | USD 8.460 | USD 8.397 |
| Low | USD 9.895 | USD 8.960 | USD 8.800 | USD 8.045 | USD 8.105 |
Performance
| 1 day | -2.05% | ||
| 1 week | -18.47% | ||
| Current month | -16.29% | ||
| 1 month | -21.47% | ||
| 3 months | -4.47% | ||
| 6 months | -4.36% | ||
| Current year | +4.10% | ||
| 1 year | +0.62% | ||
| 3 years | +18.71% | ||
| 5 years | -46.58% | ||
| 10 years | +87.53% |
Volumes
marketsDaily volume
3,591,765
Estimated daily volume
3,591,765
Avg. Volume 20 sessions
3,603,289
Daily volume ratio
1
Avg. Volume 20 sessions USD
29,258,706.68
Record volume 1
40,095,470
Record volume 2
37,550,050
Record volume 3
37,366,410
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
2,074,945,052
Net sales (USD)
874,837,000
Number of employees
435
Sales / Employee (USD)
2,011,120
Free-Float
94.77 %
Free-Float capitalization (USD)
1,966,399,474
Average Daily Capital Traded
1.41%
Indicators
Moving average 5 days
8.848
Moving average 20 days
9.675
Moving average 50 days
9.681
Moving average 100 days
9.294
Price spread / (MMA5)
+8.97%
Price spread / (MMA20)
+19.15%
Price spread / (MMA50)
+19.23%
Price spread / (MMA100)
+14.46%
RSI 9 days
23.01
RSI 14 days
31.3
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.05% | -18.47% | +0.62% | +18.71% | 2.07B | |
| -2.11% | -1.68% | +44.52% | +95.15% | 66.93B | |
| -0.23% | -4.45% | +30.39% | +73.64% | 61.97B | |
| +1.67% | +2.47% | -11.23% | +388.34% | 28.27B | |
| -1.05% | -4.43% | +30.56% | +10.07% | 24.59B | |
| +0.34% | -6.78% | -7.27% | -17.99% | 24.3B | |
| +0.43% | -3.37% | +14.85% | -19.29% | 19.41B | |
| -3.03% | -2.29% | +185.12% | +334.07% | 16.77B | |
| -1.94% | -4.94% | -5.29% | +495.65% | 14.18B | |
| -2.28% | -4.90% | +43.64% | +155.21% | 13.91B | |
| Average | -1.02% | -4.96% | +32.59% | +153.36% | 27.24B | |
| Weighted average by Cap. | -0.85% | -3.18% | +33.21% | +132.79% |
Historical Quotes: BioCryst Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
560043555f685ccad36d6298d8.mXYsocctKUfbqbaBK92h8T3_CXlAzwPgLt_dtud4Xeg.xhFq6KlKfBOS8ODlc4Xgs06qOBMMtmuEfLbs-4wXcN7cBEXTpElcdarKwQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 06:00:00 am | 8.120 | 523,481 | 2,861,006 |
| 05:59:59 am | 8.120 | 100 | 2,337,525 |
| 05:59:59 am | 8.115 | 200 | 2,337,425 |
| 05:59:59 am | 8.115 | 360 | 2,337,225 |
| 05:59:59 am | 8.115 | 200 | 2,336,865 |
| 05:59:59 am | 8.115 | 200 | 2,336,665 |
| 05:59:59 am | 8.110 | 200 | 2,336,465 |
| 05:59:59 am | 8.115 | 200 | 2,336,265 |
| 05:59:59 am | 8.115 | 200 | 2,336,065 |
| 05:59:59 am | 8.115 | 200 | 2,335,865 |
Price Extremes
| 1 week | 8.04 |  | 9.4 |
| 1 month | 8.04 | | 10.63 |
| Current year | 6.23 | | 11.22 |
| 1 year | 6 | | 11.22 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
Monthly variations
Annual variations
| 2026 | +4.10% | ||
| 2025 | +3.72% | ||
| 2024 | +25.54% | ||
| 2023 | -47.82% | ||
| 2022 | -17.11% | ||
| 2021 | +85.91% | ||
| 2020 | +115.94% | ||
| 2019 | -57.25% | ||
| 2018 | +64.36% | ||
| 2017 | -22.43% | ||
| 2016 | -38.66% | ||
| 2015 | -15.13% | ||
| 2014 | +60.00% | ||
| 2013 | +435.21% | ||
| 2012 | -42.51% | ||
| 2011 | -52.22% | ||
| 2010 | -19.97% | ||
| 2009 | +371.53% | ||
| 2008 | -77.83% | ||
| 2007 | -46.54% | ||
| 2006 | -30.99% | ||
| 2005 | +189.79% | ||
| 2004 | -15.62% | ||
| 2003 | +613.54% | ||
| 2002 | -75.76% | ||
| 2001 | -40.23% | ||
| 2000 | -77.54% | ||
| 1999 | +321.43% | ||
| 1998 | 0.00% | ||
| 1997 | -57.25% | ||
| 1996 | +77.03% | ||
| 1995 | +100.00% | ||
| 1994 | -28.85% |
- Stock Market
- Stocks
- BCRX Stock
- Quotes BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
